Location permission needed for a better experience.
How can we help you?
CV
Memberships
Publications
Education
  • 2007 Atatürk Üniversitesi Tıp Fakültesi Tıbbi Genetik
  • 1998 Atatürk Üniversitesi Tıp Fakültesi
Experience
  • 2019 Acıbadem Sağlık Grubu
  • 2019 Acıbadem Maslak Hastanesi Tıbbi Genetik Polikliniği / Tıbbi Genetik Uzmanı
  • 2019 Acıbadem Labgen Genetik Değerlendirme Merkezi / Direktör
  • 2019 Acıbadem Labmed Ankara Doku Tipleme Laboratuvarı / Supervisor
  • 2018 - 2019 Yeni Yüzyıl Üniversitesi, Gaziosmanpasa Hastanesi, Genetik Tanı Merkezi / Tıbbi Genetik Uzmanı / İstanbul
  • 2013 - 2017 Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi / Doçent Doktor / Genetik Tanı Merkezi Sorumlusu / Doku Tipleme Laboratuarı Sorumlusu / Ankara
  • 2013 Reprogenetics, Livingston, NJ, USA / Visiting Scholar
  • 2012 - 2013 Dr. Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi, Genetik Tanı Merkezi / Sorumlu Hekim / Doçent Doktor / Ankara
  • 2007 - 2012 Dr. Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi, Genetik Merkezi / Sorumlu Hekim / Uzman Doktor / Ankara
  • 2008 Charite University, Institute of Transfusion Medicine Berlin,GERMANY / Visiting Scholar
  • 2003 - 2007 Atatürk Üniversitesi Tıp Fakültesi / Dr.Ar.Gör. / Erzurum
  • 1998 - 2003 M.E.B. Sağlık Eğitim Merkezi / Pratisyen Hekim / Erzurum
Memberships
  • American Society of Human Genetics
  • Türk İmmünoloji Derneği
  • Tıbbi Genetik Derneği
  • European Society of Human Genetics
  • Transplantasyon İmmünolojisi ve Genetiği Derneği
Publications
  • Homozygous SQSTM1 nonsense variant identified in a patient with brainstem involvement, Brain Dev. 2021 Nov;43(10):1039-1043 Kilic MA, Kipoglu O, Coskun O, Karacabey BN, Yesilyurt A, Yildiz EP, Aydinli N, Caliskan
  • Association of vitamin D receptor gene FokI and TaqI polymorphisms and risk of RDS J Matern Fetal Neonatal Med. 2019 Feb 27:1-7 Ustun N, Eyerci N, Karadag N, Yesilyurt A, Zenciroglu A, Okumus N
  • Vitamin D status, serum lipid concentrations, and vitamin D receptor (VDR) gene polymorphisms in Familial Mediterranean fever Bosn, J Basic Med Sci. 2018 Feb 20;18(1):21-28. Turhan T, Doğan HO, Boğdaycioğlu N, Eyerci N, Omma A, Sari İ, Yeşilyurt A, Karaaslan Y
  • Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus Horm Res Paediatr. 2018;90(4):257-265 Ozsu E, Cizmecioglu FM, Yesiltepe Mutlu G, Yuksel AB, Calıskan M, Yesilyurt A, Hatun S
  • Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy - Phase I-II. Degener Neurol Neuromuscul Dis. 2018 Oct 26;8:63-77 Dai A, Baspinar O, Yeşilyurt A, Sun E, Aydemir Çİ, Öztel ON, Capkan DU, Pinarli F, Agar A, Karaöz E
  • Retinal and Choroidal Thickness in Adult Patients with Familial Mediterranean Fever., Ophthalmic Epidemiol. 2017 Oct;24(5):346-351. Bicer T, Celikay O, Kosker M, Alp MY, Ozisler C, Yesilyurt A, Kucuk Bicer B, Gurdal C
  • Analysis of CYP1B1 in pediatric and adult glaucoma and other ocular phenotypes, Mol Vis. 2016 Oct 17;22:1229-1238 Reis LM, Tyler RC, Weh E, Hendee KE, Kariminejad A, Abdul-Rahman O, Ben-Omran T, Manning MA, Yesilyurt A, McCarty CA, Kitchner TE, Costakos D, Semi
  • Association Between Keratoconus and Familial Mediterranean Fever in Turkey Cornea. 2016 Jan;35(1):77-80 Kosker M, Arslan N, Alp MY, Ozisler C, Acar M, Dogan AS, Yesilyurt A, Gurdal C,
  • Nonclassical Congenital Adrenal Hyperplasia and Pregnancy. Case Rep Endocrinol. 2015;2015:296924 Cuhaci N, Aydın C, Yesilyurt A, Pınarlı FA, Ersoy R, Cakir B
  • Thyroid hormone resistance in two patients with papillary thyroid microcarcinoma and their BRAFV600E mutation status Arch Endocrinol Metab. 2015 Aug;59(4):364-6. Karakose, Melia; Caliskan, Mustafa; Arslan, Muyesser Sayki; Cakal, Erman; Yesilyurt, Ahmet; Delibasi, Tuncay,
  • BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review Balkan Med J. 2015 Apr;32(2):156-66. Sahpaz, Ahmet; Onal, Binnur; Yesilyurt, Ahmet; Han, Unsal; Delibasi, Tuncay,
  • The effects of commonly used intravitreal steroids on proliferation index of ciliary body-derived mesenchymal stem cells: an in vitro study., Cutan Ocul Toxicol. 2015 Feb 25:1-5. Demir MN, Acar U, Sobaci G, Pınarlı FA, Erginturk Acar D, Beyazyıldız E, Yesilyurt A, Delibasi T
  • The contralateral extremity has also benefit from the locally administered bone marrow-derived mononuclear cells and cord blood serum in diabetic ischemic wound healing Stem Cell Rev. 2014 Feb;10(1):97-102. Ulus AT, Pınarli FA, Sonmez D, Yesilyurt A, Delibasi T.,
  • Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence, Gene. 2014 Feb 15;536(1):171-6 Simsek E, Yesilyurt A, Pinarli F, Eyerci N, Ulus AT.,
  • Association between Pre-Eclampsia and Inherited Thrombophilias Fetal Pediatr Pathol. 2013 Jun;32(3):213-7. Deveer R, Engin-Ustun Y, Akbaba E, Halisdemir B, Cakar E, Danisman N, Mollamahmutoglu L, Yesilyurt A, Candemir Z,
  • The effects of oral carvacrol treatment against H2O2 induced injury on isolated pancreas islet cells of rats, Islets. 2013 Jun 28;5(4). Dagli Gul AS, Fadillioglu E, Karabulut I, Yesilyurt A, Delibasi T.,
  • A retrospective analysis of amniocenteses performed for advanced maternal age and various other indications in Turkish women, J Matern Fetal Neonatal Med. 2013 Feb;26(3):242-5 Danisman N, Kahyaoglu S, Celen S, Kahyaoglu I, Candemir Z, Yesilyurt A, Cakar ES,
  • OTX2 mutations contribute to the otocephaly-dysgnathia complex,OTX2 J Med Genet Yesilyurt A, Boyadjiev SA,Kayserili H, Loget P, Carles D,Sergi C, Puvabanditsin S, Chen CP, Etchevers HC,Katsanis N, Mercer CL,Calvas P,Jabs EW J 2012 Chassaing N,Sorrentino S, Davis EE, Martin-Coignard D, Iacovelli A, Paznekas W, Webb BD, Faye-Petersen O, Encha-Razavi F, Lequeux L, Vigouroux A,
  • The relationship between carbon monoxide intoxication and sister chromatid exchange in lymphocyte cells Toxicol Ind Health. 2012 Oct 31. Tarik O, Zeynep O, Hasan D, Mustafa U, Ahmet Y, Mevlit I, Sahin A.,
  • Partial trisomy 8p (8p11.2-->pTER) and deletion of 13q (13q32-->qTER): case report., Genet Couns. 2011;22(1):35-40. Yeşilyurt A, Dilli D, Oguz S, Dilmen U, Altug N, Candemir Z,
  • The Protective Effect of Erdosteine on Radiocontrast Induced Nephrotoxicity in Rats Environ Toxicol. 2011 Aug;26(4):395-402 Yesilyurt A, İ. A. Erden, İ. Bilgic, G. Erden, A. Albayrak,
  • Squamous cell carcinoma of the vulva in a virgin patient with Turner syndrome J Gynecol Oncol. 2011 Sep;22(3):211-3. Tapisiz OL, Topcu O, Gungor T, Ozdal B, Sirvan L, Yesilyurt A
  • Assisted Reproductive Treatment Applıcations In Men With Normal Phenotype But 45,X/46,XY Mosaic Karyotype: Clinical And Genetic Perspectives", Taiwanese Journal of Obstetrics and Gynecology (ISI) , 199-202 pp., 2010 , DOI: 10.1016/S1028-4559(10)60042-3 S. Kilic, B.Yukse, E. Ozdemir, A. Yesilyurt, N. Tasdemir, I. Keskin, M. Dogan,
  • Evaluation of Ribavirin Genotoxicity with Sister Chromatid Exchange and Micronuclei Assays in Humans Turkish Journal of Medical Sciences (ISI) , 241-246 pp., 2009 , DOI: 10.3906/sag-0804-26 A. Tatar, Z. Özkurt, A. Hacımüftüoğlu, A. Yesilyurt, S. Vançelik
  • Primary Hypogonadism, Partial Alopecia, and Mullerian Hypoplasia: Report of a Third Family and Review", American Journal of Medical Genetics: Part A (ISI) , 501-504 pp., 2009 , DOI: 10.1002/ajmg.a.32645 A. Tatar, Z. Ocak, A. Tatar, A. Yesilyurt, B. Borekci,S. Oztas
  • A chromosomal-effect study of intensive phototherapy versus conventional phototherapy in newborns with jaundice Mutation Research - Genetic Toxicology and Environmental Mutagenesis (ISI) , 17-20 pp., 2009 , DOI: 10.1016/j.mrgentox.2009.03.008 A. Karadag, A. Yesilyurt, S. Unal, İ. Keskin, H. Demirin, N. Uras, U. Dilmen, M. M. Tatlı
  • Evaluation of the genotoxic effects of chronic low-dose ionizing radiation exposure on nuclear medicine workers Nuclear Medicine and Biology (ISI) , 575?578 pp., 2009 , DOI: 10.1016/j.nucmedbio.2009.02.003 A. Sahin, A. Tatar, S. Oztas, B. Seven, E. Varoglu, A. Yesilyurt, A. K. Ayan
  • Klinefelter Sendromlu Hastalarımızın Tese ve ICSI Sonuçları Van Tıp Dergisi , 63-66 pp., 2009 E. Özdemir, U. Öztürk, S. Kılıç, A. Yeşilyurt, N. Cicek, A. İmamoğlu
  • Seckel Syndrome with Spontaneous Chromosomal Instability Turkish Journal of Medical Sciences (ISI) , 77-81 pp., 2008 A. Tatar, Z. Ocak, H. Döneray, E. Işık, A. Yeşilyurt, B. Özkan, S. Öztaş
  • Genotoxic effect of albendazole in pediatric patients with hepatic hydatid disease International Journal of Infectious Diseases (ISI) , 446?449 pp., 2007 , DOI: 10.1016/j.ijid.2007.01.002 S. Oztas, A. B. Salman, A. Tatar, M. Yigiter, H. Yazgi, M. Ertek, A. Yesilyurt, Z. Ocak

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 444 55 44 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP